Recently, Pfizer also successfully secured the ownership of GLP-1 biotechnology company Metsera after a surprise bidding conflict, adding Metseras injectable asset, MET-097i (which is in Phase 2b testing and has the potential for once-a-month dosing), to its portfolio
We provide nutritional guidance tailored to GLP-1 therapy, lifestyle coaching for sustainable habits, progress tracking and accountability, and integration with other wellness services if desired
This titration minimizes side effects, particularly the nausea and gastrointestinal discomfort that comes with GLP-1 receptor agonists
- The pain management compounding from Medwise has been a lifesaver for me
2023 Apr;24(2):69 Zahabi G, Ilic V, Garca-Ramos A, Cokorilo N